Precipio Expands ICE COLD-PCR™ Menu for Breast, Colon and Endometrial Cancers
23 oct. 2018 09h15 HE
|
Precipio, Inc.
Ultra-sensitive assays for PIK3CA exons 9 & 20 detect mutations that impact critical therapeutic decisions NEW HAVEN, Conn., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO),...
Innovation Behind Precipio’s ICE-COLD PCR™ Platform Spotlighted in Media
18 oct. 2018 07h36 HE
|
Precipio, Inc.
Articles Highlight Scientific and Economic Advantages Provided by Precipio’s Technology NEW HAVEN, Conn., Oct. 18, 2018 (GLOBE NEWSWIRE) -- The scientific and economic advantages of the...
Precipio Expands ICE-COLD PCR™ Lung Cancer Mutation Detection Offering
20 sept. 2018 07h37 HE
|
Precipio, Inc.
New kit examines most relevant EGFR exons that impact therapeutic decisions for lung cancer patients NEW HAVEN, Conn., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO), announced...
Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology
06 juin 2018 07h38 HE
|
Precipio, Inc.
NEW HAVEN, Conn., June 06, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced the award of US patent No. 9,957,556 entitled FULL COLD-PCR...